There are 3397 resources available
557MO - Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial
Presenter: Clelia Coutzac
Session: Mini oral session - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: YO Masterclass: Tackling new challenges facing young investigators
Resources:
Slides
Webcast
Invited Discussant LBA31, 556MO, LBA32 and 557MO
Presenter: Raghav Sundar
Session: Mini oral session - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
558MO - Circulating tumor (ct)DNA as a prognostic biomarker in patients (pts) with resected colorectal cancer (CRC): An updated 24 months (mos) disease free survival (DFS) analysis from GALAXY study (CIRCULATE-Japan)
Presenter: Yoshiaki Nakamura
Session: Mini oral session - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
559MO - Rechallenge with EGFR inhibitors in ctDNA RAS/BRAF wild type refractory metastatic colorectal cancer: Individual patients’ data pooled analysis from 4 phase II trials
Presenter: Davide Ciardiello
Session: Mini oral session - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
560MO - Maintenance with 5FU/LV-Aflibercept after induction with FOLFIRI-Aflibercept vs FOLFIRI-Aflibercept until progression in older patients (pts) in 2nd line metastatic colorectal cancer (mCRC): The randomized AFEMA trial
Presenter: Pilar García Alfonso
Session: Mini oral session - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant 558MO, 559MO and 560MO
Presenter: Jeanne Tie
Session: Mini oral session - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast
Welcome and introductions
Presenter: Luis Paz-Ares
Session: Janssen Pharmaceutica N.V. - Transforming treatment approaches for patients with EGFR-mutant NSCLC
Resources:
Webcast
Welcome and introduction
Presenter: Christopher Sweeney
Session: Astellas Pharma Europe Ltd - Putting the patient first: Considering treatment choice and maximising quality of life in mHSPC
Resources:
Webcast